Search Results

There are 14125 results for: content related to: Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease

  1. You have free access to this content
    Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 47, Issue 1, January 2018, Pages: 16–25, S. Sookoian and C. J. Pirola

    Version of Record online : 30 OCT 2017, DOI: 10.1111/apt.14401

  2. You have free access to this content
    Meta-analysis: vitamin D and non-alcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 3, August 2013, Pages: 246–254, M. Eliades, E. Spyrou, N. Agrawal, M. Lazo, F. L. Brancati, J. J. Potter, A. A. Koteish, J. M. Clark, E. Guallar and R. Hernaez

    Version of Record online : 20 JUN 2013, DOI: 10.1111/apt.12377

  3. You have free access to this content
    Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 9, November 2015, Pages: 1051–1063, A. Wieland, D. N. Frank, B. Harnke and K. Bambha

    Version of Record online : 24 AUG 2015, DOI: 10.1111/apt.13376

  4. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration

    Alimentary Pharmacology & Therapeutics

    Volume 47, Issue 2, January 2018, Pages: 268–278, Y. A. Patel, E. J. Gifford, L. M. Glass, R. McNeil, M. J. Turner, B. Han, D. Provenzale, S. S. Choi, C. A. Moylan and C. M. Hunt

    Version of Record online : 8 NOV 2017, DOI: 10.1111/apt.14411

  5. You have free access to this content
    Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case–control study

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 4, February 2015, Pages: 368–378, I. Vodkin, M. A. Valasek, R. Bettencourt, E. Cachay and R. Loomba

    Version of Record online : 11 DEC 2014, DOI: 10.1111/apt.13052

  6. You have free access to this content
    Review article: the management of paediatric nonalcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 10, November 2014, Pages: 1155–1170, E. B. Mitchel and J. E. Lavine

    Version of Record online : 29 SEP 2014, DOI: 10.1111/apt.12972

  7. You have free access to this content
    PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 5, March 2014, Pages: 532–539, J. Shen, G. L.-H. Wong, H. L.-Y. Chan, H.-Y. Chan, D. K.-W. Yeung, R. S.-M. Chan, A. M.-L. Chim, A. W.-H. Chan, P. C.-L. Choi, J. Woo, W. C.-W. Chu and V. W.-S. Wong

    Version of Record online : 13 JAN 2014, DOI: 10.1111/apt.12609

  8. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 46, Issue 11-12, December 2017, Pages: 1061–1069, C. R. Wong, B. Njei, M. H. Nguyen, A. Nguyen and J. K. Lim

    Version of Record online : 28 SEP 2017, DOI: 10.1111/apt.14342

  9. You have free access to this content
    Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 1, January 2016, Pages: 83–95, I. Doycheva, J. Cui, P. Nguyen, E. A. Costa, J. Hooker, H. Hofflich, R. Bettencourt, S. Brouha, C. B. Sirlin and R. Loomba

    Version of Record online : 15 SEP 2015, DOI: 10.1111/apt.13405

  10. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey

    Alimentary Pharmacology & Therapeutics

    Volume 46, Issue 10, November 2017, Pages: 974–980, R. J. Wong, B. Liu and T. Bhuket

    Version of Record online : 15 SEP 2017, DOI: 10.1111/apt.14327

  11. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population

    Alimentary Pharmacology & Therapeutics

    Volume 46, Issue 4, August 2017, Pages: 447–456, T. C.-F. Yip, A. J. Ma, V. W.-S. Wong, Y.-K. Tse, H. L.-Y. Chan, P.-C. Yuen and G. L.-H. Wong

    Version of Record online : 6 JUN 2017, DOI: 10.1111/apt.14172

  12. You have full text access to this OnlineOpen article
    Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 8, October 2016, Pages: 877–889, M. Munteanu, D. Tiniakos, Q. Anstee, F. Charlotte, G. Marchesini, E. Bugianesi, M. Trauner, M. Romero Gomez, C. Oliveira, C. Day, J.-F. Dufour, S. Bellentani, Y. Ngo, S. Traussnig, H. Perazzo, O. Deckmyn, P. Bedossa, V. Ratziu, T. Poynard and the FLIP Consortium and the FibroFrance Group

    Version of Record online : 23 AUG 2016, DOI: 10.1111/apt.13770

  13. You have free access to this content
    Non-alcoholic fatty liver diseases and risk of colorectal neoplasia

    Alimentary Pharmacology & Therapeutics

    Volume 45, Issue 2, January 2017, Pages: 345–353, J. S. Ahn, D. H. Sinn, Y. W. Min, S. N. Hong, H. S. Kim, S.-H. Jung, S. Gu, P.-L. Rhee, S. W. Paik, H. J. Son and G.-Y. Gwak

    Version of Record online : 18 NOV 2016, DOI: 10.1111/apt.13866

  14. You have free access to this content
    Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 6, September 2015, Pages: 731–740, V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan, D. K.-W. Yeung, R. S.-M. Chan, A. M.-L. Chim, C. K.-M. Chan, Y.-K. Tse, J. Woo, W. C.-W. Chu and H. L.-Y. Chan

    Version of Record online : 23 JUL 2015, DOI: 10.1111/apt.13327

  15. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 45, Issue 11, June 2017, Pages: 1403–1412, J. J. Kim, D. Kim, J. Y. Yim, J. H. Kang, K. H. Han, S. M. Kim, K. R. Hwang, S. Y. Ku, C. S. Suh, S. H. Kim and Y. M. Choi

    Version of Record online : 30 MAR 2017, DOI: 10.1111/apt.14058

  16. You have free access to this content
    Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 5, September 2015, Pages: 582–590, E. C. Verna, J. Patel, R. Bettencourt, P. Nguyen, C. Hernandez, M. A. Valasek, T. Kisselva, D. A. Brenner and R. Loomba

    Version of Record online : 29 JUN 2015, DOI: 10.1111/apt.13292

  17. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients

    Alimentary Pharmacology & Therapeutics

    Volume 46, Issue 2, July 2017, Pages: 85–95, S. Sookoian and C. J. Pirola

    Version of Record online : 2 MAY 2017, DOI: 10.1111/apt.14112

  18. You have free access to this content
    Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 10, November 2014, Pages: 1209–1222, L. Fedchuk, F. Nascimbeni, R. Pais, F. Charlotte, C. Housset, V. Ratziu and forthe LIDO Study Group

    Version of Record online : 29 SEP 2014, DOI: 10.1111/apt.12963

  19. You have free access to this content
    Review article: the diagnosis of non-alcoholic fatty liver disease – availability and accuracy of non-invasive methods

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 4, February 2013, Pages: 392–400, D. Festi, R. Schiumerini, L. Marzi, A. R. Di Biase, D. Mandolesi, L. Montrone, E. Scaioli, G. Bonato, G. Marchesini-Reggiani and A. Colecchia

    Version of Record online : 20 DEC 2012, DOI: 10.1111/apt.12186

  20. You have free access to this content
    Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 12, June 2015, Pages: 1271–1280, J. Cui, B. Ang, W. Haufe, C. Hernandez, E. C. Verna, C. B. Sirlin and R. Loomba

    Version of Record online : 15 APR 2015, DOI: 10.1111/apt.13196

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 43, Issue 6, 754, Version of Record online: 15 FEB 2016